1.Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. Cancer J Clin. 2014;64(1):9–29.
2.Cancer Australia. Prostate cancer statistics: Australian Government 2018 [9/10/2018]. Available from: https://prostate-cancer.canceraustralia.gov.au/statistics.
3.Gliklich RE, Dreyer NA, Leavy MB. AHRQ Methods for Effective Health Care. Registries for Evaluating Patient Outcomes: A User’s Guide. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014.
4.McNeil J, Evans S, Brennan A, Read C., editor. Registry Science Handbook. Melbourne; Monash University; 2017.
5.Evans SM, Millar JL, Wood JM, Davis ID, Bolton D, Giles GG, et al. The Prostate Cancer Registry: monitoring patterns and quality of care for men diagnosed with prostate cancer. BJU International. 2013;111(4b):E158-E166.
6.Nag N, Millar J, Davis ID, Costello S, Duthie JB, Mark S, et al. Development of Indicators to Assess Quality of Care for Prostate Cancer. EurUrol Focus. 2018;4(1):57–63.
7.Reese AC, Cowan JE, Brajtbord JS, Harris CR, Carroll PR, Cooperberg MR. The quantitative Gleason score improves prostate cancer risk assessment. Cancer. 2012;118(24):6046–6054.
8.National Comprehensive Cancer Network. National Comprehensive Cancer Network: NCCN History 2017 [9/10/2018]. Available from: https://www.nccn.org/about/history.aspx.
9.Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali W. New ICD–10 version of the Charlson Comorbidity Index predicted in-hospital mortality. J Clin Epi 2004. 2004;57:1288–94.
10.Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali W. New ICD–10 version of the Charlson Comorbidity Index predicted in-hospital mortality. J Clin Epi 2004. 2004;57:1288–94.
11.Charlson M, Pompei P, Ales K, MacKenzie C. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
12.Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN. The self-administered comorbidity questionnaire: A new method to assess comorbidity for clinical and health services research. Arthritis Care Res. 2003;49(2):156–163.
13.Australian Bureau of Statistics. Census of Population and Housing: Socio-Economic Indexes for Areas (SEIFA), Australia. Canberra: Australian Bureau of Statistics; 2018.
14.Wongpakaran N, Wongpakaran T, Wedding D, Gwet KL. A comparison of Cohen’s Kappa and Gwet’s AC1 when calculating inter-rater reliability coefficients: a study conducted with personality disorder samples. BMC Med Res Methodol. 2013;13(1):61.
15.Gwet K. Inter-Rater Reliability: Dependency on Trait Prevalence and Marginal Homogeneity. Stat Methods Inter-Rater Reliabil Assess Ser. 2002;2:1–9.
16.Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159–174.
17.Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC. Natural history of progression after PSA elevation following radical prostatectomy. JAMA. 1999;281(17):1591–1597.
18.Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW. Can comorbidity be measured by questionnaire rather than medical chart review? Med Care. 1996;34(1):73–84.
19.Lee H-J, Choi EJ, Nahm FS, Yoon IY, Lee PB. Prevalence of unrecognized depression in patients with chronic pain without a history of psychiatric diseases. Kor J Pain. 2018;31(2):116–124.
20.D’Astolfo CJ, Humphreys BK. A chart review of reported musculoskeletal pain in an Ontario long term care facility. BMC Geriatr. 2006;6:5.
21.Lo TKT, Parkinson L, Cunich M, Byles J. Discordance between self-reported arthritis and musculoskeletal signs and symptoms in older women. BMC Musculoskel Dis. 2016;17:494.
22.Bedson J, Mottram S, Thomas E, Peat G. Knee pain and osteoarthritis in the general population: what influences patients to consult? Fam Prac. 2007;24(5):443–453.
23.Kriegsman DMW, Penninx BWJH, Van Eijk JTM, Boeke AJP, Deeg DJH. Self-reports and general practitioner information on the presence of chronic diseases in community dwelling elderly: A study on the accuracy of patients’ self-reports and on determinants of inaccuracy. J Clin Epidemil. 1996;49(12):1407–1417.
24.O’Malley KJ, Cook KF, Price MD, Wildes KR, Hurdle JF, Ashton CM. Measuring Diagnoses: ICD Code Accuracy. Health Serv Res. 2005;40(5 Pt 2):1620–1639.
25.Romano PS, Mark, D. Bias in the coding of hospital discharge data and its implications for quality assessment. JSTOR. 1994;32(1):81–90.
26.Faculty of Health Sciences, editor. The International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Australian modification (ICD–10-AM). Sydney: National Centre for Classification in Health; 2006.
27.Romano PS, Roos LL, Luft HS, Jollis JG, Doliszny K, The Ischemic Heart Disease Patient Outcomes Research T. A comparison of administrative versus clinical data: coronary artery bypass surgery as an example. J Clin Epidemiol. 1994;47(3):249–260.
28.Needham DM, Scales DC, Laupacis A, Pronovost PJ. A systematic review of the Charlson comorbidity index using Canadian administrative databases: a perspective on risk adjustment in critical care research. J Crit Care. 2005;20(1):12–19.
29.Leal JR, Laupland KB. Validity of ascertainment of co-morbid illness using administrative databases: a systematic review. Clinical Microbiol Infect. 2010;16(6):715–721.
30.Susser SR, McCusker J, Belzile E. Comorbidity information in older patients at an emergency visit: self-report vs. administrative data had poor agreement but similar predictive validity. J Clin Epidemiol. 2008;61(5):511–515.
31.Scott IA, Ward M. Public reporting of hospital outcomes based on administrative data: risks and opportunities. Med J Aus. 2006;184(11):571–575.
32.Humphries KH, Rankin JM, Carere RG, Buller CE, Kiely FM, Spinelli JJ. Co-morbidity data in outcomes research Are clinical data derived from administrative databases a reliable alternative to chart review? J Clin Epidemiol. 2000;53(4):343–349.
33.Okura Y, Urban LH, Mahoney DW, Jacobsen SJ, Rodeheffer RJ. Agreement between self-report questionnaires and medical chart data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol. 2004;57(10):1096–1103.
34.Dickerson LM, Ye X, Sack JL, Hueston WJ. Glycemic control in medical inpatients with type 2 diabetes mellitus receiving sliding scale insulin regimens versus routine diabetes medications: a multicenter randomized controlled trial. Annals Fam Med. 2003;1(1):29–35
35.Olomu AB, Corser WD, Stommel M, Xie Y, Holmes-Rovner M. Do self-report and medical chart comorbidity data predict longitudinal functional capacity and quality of life health outcomes similarly? BMC Health Serv Res. 2012;12:398.
36.Stolwijk C, van Tubergen A, Ramiro S, Essers I, Blaauw M, van der Heijde D, et al. Aspects of validity of the self-administered comorbidity questionnaire in patients with ankylosing spondylitis. Rheumatol. 2014;53(6):1054–1064.
37.Baron M, Schieir O, Hudson M, Steele R, Janelle-Montcalm A, Bernstein J, et al. Evaluation of the clinimetric properties of the Early Inflammatory Arthritis—self-administered comorbidity questionnaire. Rheumatol. 2009;48(4):390–394.
38. Kim AH, Roberts C, Feagan BG, Banerjee R, Bemelman W, Bodger K, et al. Developing a Standard Set of Patient-Centred Outcomes for Inflammatory Bowel Disease-an International, Cross-disciplinary Consensus.J Crohns Colitis. 2018;12(4):408–418